Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2509622122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Sara Bizzotto und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston, MA 02115. Hauptthemen laut MEDLINE: Transcriptome, Focal Cortical Dysplasia, Epilepsy, Cerebral Cortex. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
While it is widely accepted that somatic variants that activate the PI3K-mTOR pathway are a major cause of drug-resistant focal epilepsy, typically associated with focal cortical dysplasia (FCD) type 2, understanding the mechanism of epileptogenesis requires identifying genotype-associated changes at the single-cell level, which is technically challenging with existing methods. Here, we performed single-nucleus RNA-sequencing (snRNA-seq) of 18 FCD type 2 samples removed surgically for treatment of drug-resistant epilepsy, and 17 non-FCD control samples, and analyzed additional published data comprising >400,000 single nuclei. We also performed simultaneous single-nucleus genotyping and gene expression analysis using two independent approaches: 1) a method that we called genotyping of transcriptomes enhanced with nanopore sequencing (GO-TEN) that combines targeted cDNA long-read sequencing with snRNA-seq, 2) ResolveOME snRNA-seq and DNA genotyping. snRNA-seq showed similar cell identities and proportions between cases and controls, suggesting that mosaic pathogenic variants in PI3K-mTOR pathway genes in FCD exert their effect by disrupting transcription in conserved cell types. GO-TEN and ResolveOME analyses confirmed that pathogenic variant-carrying cells have well-differentiated neuronal or glial identities, with enrichment of variants in cells of the neuroectodermal lineage, pointing to cortical neural progenitors as possible loci of somatic mutation. Within FCD type 2 lesions, we identified upregulation of PI3K-mTOR signaling and related pathways in variant-carrying neurons, downregulation of these pathways in non-variant-carrying neurons, as well as associated changes in microglial activation, cellular metabolism, synaptic homeostasis, and neuronal connectivity, all potentially contributing to epileptogenesis. These genotype-specific changes in mosaic lesions highlight potential disease mechanisms and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics and Genomics, Manton Center for Orphan Disease Research, Boston, MA 02115.
- Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115.
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
- Imagine Institute, Team Somatic Mosaicism in Neurodevelopment and Disease, Université Paris Cité, Paris 75015, France.
- Harvard/Massachusetts Institute of Technology MD-PhD Program, Harvard Medical School, Boston, MA 02115.
- Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
ORCID-Profile: Maya Talukdar, August Yue Huang, Michael S Hildebrand, Christopher A Walsh
Förderung
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NIA NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- Howard Hughes Medical Institute (HHMI)
- NICHD NIH HHS
- HHS | National Institutes of Health (NIH)
Zitieren
APA
Bizzotto, S., Talukdar, M., Stronge, E. A., Ramirez, R. B., Yang, Y., Huang, A. Y., Hu, Q., Hou, Y., Hylton, N. K., Finander, B., Tillett, A., Zhou, Z., Chhouk, B. H., D'Gama, A. M., Yang, E., Green, T. E., Reutens, D. C., Mullen, S. A., Scheffer, I. E., …, & Walsh, C. A. (2025). Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2509622122
Vancouver
Bizzotto S, Talukdar M, Stronge EA, Ramirez RB, Yang Y, Huang AY, et al. Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2509622122
BibTeX
@article{Bizzotto2025,
author = {Bizzotto, Sara and Talukdar, Maya and Stronge, Edward A and Ramirez, Rosita B and Yang, Yingxi and Huang, August Yue and Hu, Qiwen and Hou, Yingping and Hylton, Norma K and Finander, Benjamin and Tillett, Ashton and Zhou, Zinan and Chhouk, Brian H and D'Gama, Alissa M and Yang, Edward and Green, Timothy E and Reutens, David C and Mullen, Saul A and Scheffer, Ingrid E and Hildebrand, Michael S and Buono, Russell J and Blümcke, Ingmar and Poduri, Annapurna H and Khoshkhoo, Sattar and Walsh, Christopher A},
title = {Cell-type-informed genotyping of mosaic focal epilepsies reveals cell-autonomous and non-cell-autonomous disease-associated transcriptional programs},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2509622122}
}
EUVIMED